Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × Gynecologic × Clear all

NCT05756907 2026-02-03

Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Terminated

GynecologicOther solid neoplasm

Advanced Solid Tumor